United Bankshares achieved solid returns, boosted by strong earnings and robust credit quality. Learn more about UBSI stock's ...

Schwab Intermediate-Term U.S. Treasury ETF has low-cost, liquid exposure to 3–10 year U.S. Treasuries and benefits from rate cut probabilities. See more on SCHR here.

Dillard's Q2 beats expectations, but long-term declines and a lack of reinvention signal risks. See here to know why a 'sell' ...

AES stock shows potential for risk-tolerant investors with low valuations, improving margins, and renewables growth. Read ...

CoreWeave is a strong buy. With a $30.1B backlog, 207% YoY Q2 revenue growth, and US-focused AI data centers, read more on ...

Agricultural derivatives are witnessing a structural shift in how participants manage risk, express a view and trade around ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

HighPeak Energy has strengthened its finances, addressing its debt position. Read more on what this may mean for an ...

The US path to a much anticipated rate cut was well-drawn, particularly after Tuesday's CPI report coming along the Fed's ...

Claritev shows revenue growth & client wins, but extreme leverage & legal risks raise concerns. Insider buying adds ...

XXRP offers 2x daily XRP exposure. Learn why this ETF needs to be handled with extreme caution and doesn't suit long-term ...

Eli Lilly insiders made notable stock purchases in August, but competitive pressures and pricing risks make me question its ...